Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes and Other Predictors on Corneal Transplant Endothelial Cell Loss and Success

NCT07217249 is registered in ClinicalTrials.gov with Case Western Reserve University as lead sponsor.

NCT NCT07217249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07217249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes and Other Predictors on Corneal Transplant Endothelial Cell Loss and Success
Lead sponsor
Case Western Reserve University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
December 3, 2025
Completion date
April 30, 2030
Enrollment
570 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

corneal endothelial decompensation, fuchs endothelial corneal dystrophy